Caption Management, LLC Arcturus Therapeutics Holdings Inc. Call Options Transaction History

Caption Management, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$24.35 - $44.39 $608,750 - $1.11 Million	-25,000 Reduced 29.41%	60,000 $1.46 Million
Q1 2024 May 15, 2024	SELL	$31.23 - $42.99 $156,150 - $214,950	-5,000 Reduced 5.56%	85,000 $2.87 Million
Q4 2023 Feb 14, 2024	BUY	$17.71 - $32.97 $531,300 - $989,100	30,000 Added 50.0%	90,000 $2.84 Million
Q3 2023 Nov 14, 2023	BUY	$25.44 - $37.35 $1.53 Million - $2.24 Million	60,000 New	60,000 $1.53 Million
Q1 2023 May 15, 2023	BUY	$14.72 - $23.97 $441,600 - $719,100	30,000 New	30,000 $719,000
Q2 2022 Aug 15, 2022	BUY	$12.26 - $31.17 $245,200 - $623,400	20,000 Added 200.0%	30,000 $472,000
Q3 2021 Nov 12, 2021	BUY	$27.88 - $58.25 $278,800 - $582,500	10,000 New	10,000 $478,000

179

25.6M

195K

133K

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $450M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.